NDC 44206-418
Carimune Nanofiltered
Human Immunoglobulin G
Carimune Nanofiltered is a Intravenous Injection, Powder, Lyophilized, For Solution in the Plasma Derivative category. It is labeled and distributed by Csl Behring Ag. The primary component is Human Immunoglobulin G.
| Product ID | 44206-418_6d78337d-6fba-4156-a522-1c03c9181489 |
| NDC | 44206-418 |
| Product Type | Plasma Derivative |
| Proprietary Name | Carimune Nanofiltered |
| Generic Name | Human Immunoglobulin G |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2009-02-10 |
| Marketing End Date | 2021-05-31 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102367 |
| Labeler Name | CSL Behring AG |
| Substance Name | HUMAN IMMUNOGLOBULIN G |
| Active Ingredient Strength | 12 g/1 |
| Pharm Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [CS] |
| NDC Exclude Flag | N |
Packaging
NDC 44206-418-12
1 VIAL, SINGLE-USE in 1 CARTON (44206-418-12) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (44206-418-92)
| Marketing Start Date | 2009-02-10 |
| Marketing End Date | 2021-05-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 44206-418-92 [44206041892]
Carimune Nanofiltered INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102367 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | EA |
| Marketing Start Date | 2012-11-09 |
| Marketing End Date | 2021-05-31 |
NDC 44206-418-12 [44206041812]
Carimune Nanofiltered INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102367 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | EA |
| Marketing Start Date | 2009-02-10 |
| Marketing End Date | 2021-05-31 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| HUMAN IMMUNOGLOBULIN G | 12 g/1 |
Pharmacological Class
- Human Immunoglobulin G [EPC]
- Passively Acquired Immunity [PE]
- Antigen Neutralization [MoA]
- Immunoglobulins [CS]
NDC Crossover Matching brand name "Carimune Nanofiltered" or generic name "Human Immunoglobulin G"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 44206-417 | Carimune | HUMAN IMMUNOGLOBULIN G |
| 44206-418 | Carimune | HUMAN IMMUNOGLOBULIN G |
| 44206-451 | Hizentra | HUMAN IMMUNOGLOBULIN G |
| 44206-452 | Hizentra | HUMAN IMMUNOGLOBULIN G |
| 44206-454 | Hizentra | HUMAN IMMUNOGLOBULIN G |
| 44206-455 | Hizentra | HUMAN IMMUNOGLOBULIN G |
| 44206-456 | Hizentra | HUMAN IMMUNOGLOBULIN G |
| 44206-436 | Privigen | Human Immunoglobulin G |
| 44206-437 | Privigen | Human Immunoglobulin G |
| 44206-438 | Privigen | Human Immunoglobulin G |
| 44206-439 | Privigen | Human Immunoglobulin G |
Trademark Results [Carimune]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 CARIMUNE 76345581 2782715 Live/Registered |
CSL BEHRING AG 2001-12-06 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.